Company intelligence / Profile preview

Jiangsu Kanghe Medical

Jiangsu, Chinajskhcompany.en.made-in-china.com ↗

Ownership: Private
Development stage: Other

Overview

Jiangsu Kanghe Biopharmaceutical Co., Ltd. is an active Chinese biotechnology/pharmaceutical company engaged in the development of novel therapeutics, with a current pipeline including at least two drug candidates: one targeting advanced malignant solid tumors and another for knee osteoarthritis. Both programs have reached Phase 1 clinical trials by early 2025. Further details about their technology platforms, molecular targets, or broader pipeline breadth remain undisclosed in public databases.

Therapeutic areas: RheumatologyOncology
Modalities: Small moleculePossibly biologic
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Kanghe Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Kanghe Medical.

Explore the full profile